REQUEST A DEMO
Total
USD $0.00
Search more companies

Insilico Medicine Cayman Topco (Hong Kong) (英矽智能 (香港)) (Hong Kong SAR, China)

Main Activities: Research and Development in Nanotechnology | Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Insilico Medicine Cayman Topco Profile Updated: June 25, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Insilico Medicine Cayman Topco (Hong Kong) (英矽智能 (香港)) is a company in Hong Kong SAR, China, with a head office in Hong Kong. It operates in the Research and Development in Nanotechnology industry. The enterprise was incorporated on September 14, 2026. From the latest financial highlights, Insilico Medicine Cayman Topco (Hong Kong) (英矽智能 (香港)) reported a net sales revenue increase of 288.69% in Q2C2026. Its’ total assets recorded a growth of 156.5%.

Headquarters
Unit 310, 3/F, Building 8W, Phase 2, Hong Kong Science Park, Pak Shek Kok, New Territories
Hong Kong; Hong Kong;

Contact Details: Purchase the Insilico Medicine Cayman Topco (Hong Kong) (英矽智能 (香港)) report to view the information.

Website: http://insilico.com

Basic Information
Outstanding Shares:
Purchase the Insilico Medicine Cayman Topco (Hong Kong) (英矽智能 (香港)) report to view the information.
Financial Auditors:
Purchase the Insilico Medicine Cayman Topco (Hong Kong) (英矽智能 (香港)) report to view the information.
Incorporation Date:
September 14, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
8.32%
Purchase this report to view the information.
Subsidiaries
Insilico Medicine Cayman Subco (United Kingdom)
100%
Company Performance
Financial values in the chart are available after Insilico Medicine Cayman Topco (Hong Kong) (英矽智能 (香港)) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HKD. Absolute financial data is included in the purchased report.
Net sales revenue
288.69%
Total Operating Revenue
272.52%
Operating Profit
N/A
EBITDA
N/A
Net Profit/Loss for the Period
N/A
Total Assets
156.5%
Total Equity
N/A
Operating Profit Margin
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
3.68%
Debt / Equity
N/A
Quick Ratio
8.45%
Cash Ratio
4.95%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?